Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamins | 34 | 2024 | 1637 | 4.050 |
Why?
|
Dietary Supplements | 44 | 2024 | 3443 | 3.100 |
Why?
|
Cacao | 11 | 2024 | 98 | 3.080 |
Why?
|
Hypertension | 45 | 2024 | 8615 | 2.900 |
Why?
|
Cardiovascular Diseases | 64 | 2023 | 15649 | 2.520 |
Why?
|
Carotenoids | 12 | 2014 | 620 | 2.360 |
Why?
|
Vitamin D | 17 | 2024 | 3310 | 1.750 |
Why?
|
Blood Pressure | 29 | 2024 | 8541 | 1.680 |
Why?
|
Body Mass Index | 58 | 2021 | 13052 | 1.390 |
Why?
|
Testicular Neoplasms | 13 | 2024 | 805 | 1.360 |
Why?
|
Risk Factors | 167 | 2024 | 74962 | 1.300 |
Why?
|
C-Reactive Protein | 17 | 2023 | 3857 | 1.270 |
Why?
|
Flavonoids | 5 | 2021 | 447 | 1.240 |
Why?
|
Pancreatic Neoplasms | 29 | 2023 | 5443 | 1.220 |
Why?
|
Prospective Studies | 136 | 2024 | 54920 | 1.220 |
Why?
|
Diet | 24 | 2024 | 8090 | 1.200 |
Why?
|
Overweight | 12 | 2020 | 2445 | 1.190 |
Why?
|
Alcohol Drinking | 21 | 2019 | 4049 | 1.150 |
Why?
|
Middle Aged | 254 | 2024 | 223491 | 1.110 |
Why?
|
Calcium, Dietary | 5 | 2016 | 533 | 1.100 |
Why?
|
Motor Activity | 14 | 2015 | 2720 | 1.090 |
Why?
|
Aged | 217 | 2024 | 171562 | 1.040 |
Why?
|
Exercise | 25 | 2024 | 5946 | 1.000 |
Why?
|
Fatty Acids, Omega-3 | 9 | 2023 | 1398 | 0.990 |
Why?
|
Prostatic Neoplasms | 44 | 2022 | 11221 | 0.990 |
Why?
|
Antioxidants | 11 | 2014 | 1673 | 0.970 |
Why?
|
Proportional Hazards Models | 55 | 2024 | 12558 | 0.960 |
Why?
|
Double-Blind Method | 38 | 2024 | 12456 | 0.930 |
Why?
|
Feeding Behavior | 12 | 2019 | 3203 | 0.920 |
Why?
|
Vitamin E | 10 | 2022 | 874 | 0.920 |
Why?
|
Dairy Products | 6 | 2017 | 490 | 0.920 |
Why?
|
Obesity | 29 | 2024 | 13084 | 0.910 |
Why?
|
Smoking | 33 | 2021 | 9111 | 0.870 |
Why?
|
beta Carotene | 14 | 2023 | 523 | 0.870 |
Why?
|
Weight Gain | 9 | 2020 | 2356 | 0.860 |
Why?
|
Women's Health | 8 | 2016 | 2078 | 0.860 |
Why?
|
Neoplasms | 28 | 2024 | 22385 | 0.850 |
Why?
|
Physicians | 25 | 2022 | 4614 | 0.840 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2020 | 554 | 0.810 |
Why?
|
Vitamin D Deficiency | 5 | 2024 | 1389 | 0.800 |
Why?
|
Renin | 1 | 2024 | 648 | 0.800 |
Why?
|
Male | 255 | 2024 | 364902 | 0.800 |
Why?
|
Humans | 353 | 2024 | 768393 | 0.800 |
Why?
|
Ascorbic Acid | 7 | 2022 | 658 | 0.790 |
Why?
|
Fruit | 6 | 2017 | 1164 | 0.790 |
Why?
|
Case-Control Studies | 69 | 2024 | 22296 | 0.790 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2023 | 16028 | 0.790 |
Why?
|
Cause of Death | 17 | 2018 | 3728 | 0.790 |
Why?
|
Stroke | 17 | 2022 | 9742 | 0.760 |
Why?
|
Aspirin | 19 | 2024 | 3135 | 0.760 |
Why?
|
Life Style | 17 | 2022 | 3929 | 0.740 |
Why?
|
Follow-Up Studies | 71 | 2024 | 39407 | 0.730 |
Why?
|
Cholecalciferol | 7 | 2024 | 557 | 0.720 |
Why?
|
Cataract | 3 | 2024 | 837 | 0.710 |
Why?
|
Diabetes Mellitus, Type 2 | 22 | 2024 | 12241 | 0.710 |
Why?
|
Renin-Angiotensin System | 1 | 2024 | 739 | 0.680 |
Why?
|
Myocardial Infarction | 19 | 2022 | 11516 | 0.670 |
Why?
|
Randomized Controlled Trials as Topic | 37 | 2024 | 10377 | 0.670 |
Why?
|
Cohort Studies | 72 | 2024 | 41795 | 0.670 |
Why?
|
Fatty Acids, Omega-6 | 3 | 2020 | 225 | 0.660 |
Why?
|
Inflammation | 16 | 2024 | 10863 | 0.650 |
Why?
|
Fishes | 3 | 2019 | 606 | 0.650 |
Why?
|
Incidence | 49 | 2024 | 21544 | 0.640 |
Why?
|
Female | 179 | 2024 | 397089 | 0.630 |
Why?
|
Parathyroid Hormone | 2 | 2024 | 1804 | 0.620 |
Why?
|
Hearing Loss | 6 | 2024 | 786 | 0.620 |
Why?
|
Multivariate Analysis | 29 | 2020 | 12092 | 0.620 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 337 | 0.610 |
Why?
|
Food Analysis | 2 | 2012 | 103 | 0.610 |
Why?
|
Risk | 36 | 2015 | 9636 | 0.610 |
Why?
|
Coronary Disease | 19 | 2012 | 5924 | 0.610 |
Why?
|
Cholangiocarcinoma | 6 | 2020 | 562 | 0.600 |
Why?
|
Bile Duct Neoplasms | 6 | 2019 | 616 | 0.600 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2018 | 241 | 0.580 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2016 | 1133 | 0.570 |
Why?
|
Fatty Acids, Monounsaturated | 4 | 2016 | 190 | 0.560 |
Why?
|
Cisplatin | 9 | 2024 | 1661 | 0.560 |
Why?
|
Vitamin D-Binding Protein | 1 | 2018 | 130 | 0.550 |
Why?
|
Vegetables | 6 | 2017 | 1198 | 0.550 |
Why?
|
Risk Assessment | 42 | 2021 | 24318 | 0.540 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1890 | 0.540 |
Why?
|
Health Behavior | 6 | 2019 | 2647 | 0.540 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 173 | 0.540 |
Why?
|
United States | 77 | 2024 | 73150 | 0.530 |
Why?
|
Avitaminosis | 1 | 2016 | 35 | 0.530 |
Why?
|
Nutritional Status | 5 | 2022 | 1627 | 0.520 |
Why?
|
Liver Neoplasms | 10 | 2023 | 4365 | 0.510 |
Why?
|
Calcium | 4 | 2015 | 5794 | 0.500 |
Why?
|
Adult | 132 | 2024 | 223640 | 0.500 |
Why?
|
Gout | 1 | 2022 | 621 | 0.490 |
Why?
|
Tinnitus | 4 | 2023 | 197 | 0.480 |
Why?
|
Waist Circumference | 8 | 2021 | 935 | 0.480 |
Why?
|
Odds Ratio | 29 | 2019 | 9682 | 0.480 |
Why?
|
alpha-Tocopherol | 6 | 2019 | 126 | 0.470 |
Why?
|
Aged, 80 and over | 72 | 2024 | 59686 | 0.470 |
Why?
|
Postmenopause | 7 | 2020 | 2518 | 0.460 |
Why?
|
Physical Fitness | 7 | 2004 | 744 | 0.450 |
Why?
|
Mortality | 8 | 2014 | 2917 | 0.450 |
Why?
|
Dietary Fats | 5 | 2015 | 2003 | 0.450 |
Why?
|
Erythrocytes | 2 | 2015 | 2421 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 26 | 2023 | 18048 | 0.440 |
Why?
|
Adiponectin | 4 | 2023 | 1117 | 0.430 |
Why?
|
Dementia | 3 | 2023 | 2729 | 0.430 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2021 | 1755 | 0.430 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 164 | 0.430 |
Why?
|
Breast Neoplasms, Male | 4 | 2015 | 212 | 0.420 |
Why?
|
Interleukin-6 | 7 | 2020 | 3230 | 0.420 |
Why?
|
Kynurenine | 4 | 2023 | 142 | 0.420 |
Why?
|
Lipids | 8 | 2019 | 3344 | 0.420 |
Why?
|
Cholesterol, HDL | 13 | 2016 | 1820 | 0.410 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2024 | 494 | 0.410 |
Why?
|
Fibrinogen | 1 | 2016 | 891 | 0.410 |
Why?
|
Ethanol | 2 | 2014 | 1332 | 0.410 |
Why?
|
Plant Extracts | 5 | 2023 | 499 | 0.400 |
Why?
|
Tea | 4 | 2005 | 289 | 0.390 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12778 | 0.390 |
Why?
|
Cognition | 9 | 2024 | 7075 | 0.390 |
Why?
|
Sex Factors | 16 | 2024 | 10654 | 0.390 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 361 | 0.380 |
Why?
|
Fragaria | 2 | 2008 | 21 | 0.370 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2011 | 542 | 0.370 |
Why?
|
Congenital Abnormalities | 1 | 2016 | 708 | 0.370 |
Why?
|
Testosterone | 2 | 2020 | 2493 | 0.370 |
Why?
|
Vitamin A | 4 | 2017 | 611 | 0.360 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2020 | 2336 | 0.360 |
Why?
|
Aging | 7 | 2015 | 8764 | 0.350 |
Why?
|
Carcinoma, Large Cell | 3 | 2019 | 114 | 0.350 |
Why?
|
Walking | 7 | 2009 | 1201 | 0.340 |
Why?
|
Coffee | 3 | 2020 | 598 | 0.330 |
Why?
|
Survivors | 5 | 2024 | 2382 | 0.330 |
Why?
|
Diastole | 4 | 2018 | 784 | 0.330 |
Why?
|
Energy Intake | 7 | 2016 | 2145 | 0.320 |
Why?
|
Antibodies, Bacterial | 3 | 2021 | 1478 | 0.320 |
Why?
|
Colorectal Neoplasms | 10 | 2021 | 6971 | 0.320 |
Why?
|
Lung Neoplasms | 14 | 2023 | 13576 | 0.310 |
Why?
|
Gonadal Steroid Hormones | 3 | 2020 | 708 | 0.310 |
Why?
|
Anticarcinogenic Agents | 2 | 2012 | 251 | 0.310 |
Why?
|
Systole | 4 | 2018 | 937 | 0.310 |
Why?
|
Hypercholesterolemia | 4 | 2023 | 1142 | 0.310 |
Why?
|
Mendelian Randomization Analysis | 5 | 2023 | 1037 | 0.310 |
Why?
|
Health Promotion | 5 | 2022 | 2209 | 0.300 |
Why?
|
Poultry | 1 | 2008 | 79 | 0.300 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2024 | 2276 | 0.290 |
Why?
|
Helicobacter pylori | 2 | 2023 | 381 | 0.290 |
Why?
|
Neuralgia | 2 | 2024 | 622 | 0.290 |
Why?
|
Health | 1 | 2010 | 399 | 0.290 |
Why?
|
Helicobacter Infections | 2 | 2023 | 391 | 0.280 |
Why?
|
Vitamin B 6 | 3 | 2018 | 234 | 0.280 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2017 | 1252 | 0.280 |
Why?
|
Telomerase | 4 | 2016 | 752 | 0.280 |
Why?
|
Diabetes Mellitus | 7 | 2024 | 5891 | 0.280 |
Why?
|
Minerals | 4 | 2024 | 282 | 0.280 |
Why?
|
Food Handling | 1 | 2007 | 158 | 0.280 |
Why?
|
Gallbladder Neoplasms | 2 | 2019 | 191 | 0.270 |
Why?
|
Endothelium, Vascular | 4 | 2015 | 4427 | 0.270 |
Why?
|
Contraceptives, Oral, Hormonal | 2 | 2020 | 190 | 0.270 |
Why?
|
Cholesterol | 10 | 2016 | 2912 | 0.270 |
Why?
|
Linear Models | 5 | 2018 | 5878 | 0.260 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2016 | 387 | 0.260 |
Why?
|
Anthropometry | 5 | 2019 | 1343 | 0.260 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1309 | 0.250 |
Why?
|
Carbon | 2 | 2021 | 672 | 0.250 |
Why?
|
Oncogene Proteins, Fusion | 5 | 2022 | 1614 | 0.250 |
Why?
|
Adenocarcinoma | 8 | 2021 | 6406 | 0.250 |
Why?
|
Body Weight | 7 | 2015 | 4629 | 0.250 |
Why?
|
Serine Endopeptidases | 3 | 2016 | 1026 | 0.250 |
Why?
|
Age Factors | 16 | 2022 | 18471 | 0.250 |
Why?
|
Meat | 1 | 2008 | 588 | 0.240 |
Why?
|
Men's Health | 2 | 2017 | 75 | 0.240 |
Why?
|
Logistic Models | 19 | 2024 | 13323 | 0.240 |
Why?
|
Genotype | 19 | 2021 | 13042 | 0.230 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4250 | 0.230 |
Why?
|
Solanum tuberosum | 1 | 2024 | 47 | 0.230 |
Why?
|
Confidence Intervals | 9 | 2019 | 2931 | 0.230 |
Why?
|
Disease Progression | 18 | 2021 | 13646 | 0.230 |
Why?
|
Adiposity | 5 | 2019 | 1895 | 0.220 |
Why?
|
Anthocyanins | 1 | 2024 | 80 | 0.220 |
Why?
|
Breast Neoplasms | 6 | 2022 | 21162 | 0.220 |
Why?
|
Gene Expression Regulation, Neoplastic | 9 | 2021 | 8634 | 0.220 |
Why?
|
Bile Ducts, Intrahepatic | 4 | 2020 | 304 | 0.220 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2019 | 450 | 0.220 |
Why?
|
Cotinine | 3 | 2018 | 206 | 0.220 |
Why?
|
Trace Elements | 2 | 2016 | 193 | 0.220 |
Why?
|
Environment | 1 | 2009 | 1124 | 0.220 |
Why?
|
Fatty Acids | 3 | 2016 | 1815 | 0.210 |
Why?
|
Diabetic Nephropathies | 2 | 2022 | 975 | 0.210 |
Why?
|
Homocysteine | 1 | 2006 | 637 | 0.210 |
Why?
|
Prostate-Specific Antigen | 6 | 2016 | 2487 | 0.210 |
Why?
|
Body Size | 2 | 2017 | 463 | 0.210 |
Why?
|
Cardiotonic Agents | 1 | 2006 | 544 | 0.210 |
Why?
|
Chronic Disease | 4 | 2023 | 9379 | 0.210 |
Why?
|
Life Expectancy | 2 | 2014 | 1249 | 0.210 |
Why?
|
Cross-Sectional Studies | 13 | 2023 | 26375 | 0.200 |
Why?
|
Leptin | 2 | 2023 | 1597 | 0.200 |
Why?
|
Risk Reduction Behavior | 5 | 2020 | 1118 | 0.200 |
Why?
|
Health Surveys | 7 | 2019 | 4056 | 0.200 |
Why?
|
Time Factors | 20 | 2021 | 40272 | 0.190 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2016 | 348 | 0.190 |
Why?
|
Migraine Disorders | 3 | 2023 | 1713 | 0.190 |
Why?
|
Glomerular Filtration Rate | 4 | 2024 | 2226 | 0.190 |
Why?
|
Seafood | 2 | 2019 | 395 | 0.190 |
Why?
|
Golf | 2 | 2000 | 16 | 0.190 |
Why?
|
Urban Population | 1 | 2009 | 2045 | 0.190 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8747 | 0.190 |
Why?
|
Energy Metabolism | 6 | 2013 | 2906 | 0.190 |
Why?
|
Diet Surveys | 1 | 2005 | 1160 | 0.180 |
Why?
|
Xanthophylls | 4 | 2012 | 95 | 0.180 |
Why?
|
Eicosapentaenoic Acid | 3 | 2020 | 563 | 0.180 |
Why?
|
Lutein | 4 | 2012 | 123 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2952 | 0.180 |
Why?
|
Self Report | 5 | 2022 | 3766 | 0.170 |
Why?
|
Intermediate Filaments | 1 | 2021 | 171 | 0.170 |
Why?
|
Mosaicism | 2 | 2015 | 481 | 0.170 |
Why?
|
Gene Frequency | 3 | 2018 | 3617 | 0.170 |
Why?
|
Receptors, Leptin | 2 | 2023 | 350 | 0.170 |
Why?
|
Genetic Variation | 10 | 2019 | 6606 | 0.170 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2019 | 4069 | 0.170 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2021 | 313 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 11854 | 0.170 |
Why?
|
Markov Chains | 1 | 2003 | 977 | 0.170 |
Why?
|
Fusobacterium nucleatum | 1 | 2021 | 176 | 0.170 |
Why?
|
Fatigue | 2 | 2024 | 1555 | 0.170 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2017 | 716 | 0.170 |
Why?
|
Receptors, Somatomedin | 1 | 2018 | 57 | 0.160 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13697 | 0.160 |
Why?
|
Up-Regulation | 4 | 2015 | 4142 | 0.160 |
Why?
|
Bacterial Proteins | 4 | 2023 | 3838 | 0.160 |
Why?
|
Carcinoma, Renal Cell | 3 | 2019 | 3200 | 0.160 |
Why?
|
Estrone | 1 | 2020 | 234 | 0.160 |
Why?
|
Prognosis | 19 | 2022 | 30022 | 0.160 |
Why?
|
Hormones | 2 | 2020 | 870 | 0.150 |
Why?
|
Prostate | 3 | 2016 | 1781 | 0.150 |
Why?
|
Health Status | 4 | 2018 | 4094 | 0.150 |
Why?
|
Primary Prevention | 3 | 2019 | 1187 | 0.150 |
Why?
|
Kidney Neoplasms | 4 | 2019 | 4303 | 0.150 |
Why?
|
Nutrigenomics | 1 | 2018 | 23 | 0.150 |
Why?
|
Glioma | 4 | 2015 | 3526 | 0.150 |
Why?
|
Docosahexaenoic Acids | 3 | 2020 | 907 | 0.150 |
Why?
|
Quantitative Trait Loci | 3 | 2021 | 2127 | 0.150 |
Why?
|
Receptors, Adiponectin | 2 | 2023 | 82 | 0.150 |
Why?
|
Longevity | 3 | 2016 | 1077 | 0.150 |
Why?
|
Mental Disorders | 2 | 2016 | 6876 | 0.150 |
Why?
|
Deficiency Diseases | 1 | 2018 | 74 | 0.140 |
Why?
|
Catechol O-Methyltransferase | 1 | 2019 | 251 | 0.140 |
Why?
|
Biliary Tract Neoplasms | 1 | 2019 | 187 | 0.140 |
Why?
|
Vitamin B 12 | 2 | 2019 | 527 | 0.140 |
Why?
|
Genetic Loci | 3 | 2017 | 2630 | 0.140 |
Why?
|
Dietary Fiber | 3 | 2015 | 767 | 0.140 |
Why?
|
Squalene Monooxygenase | 1 | 2016 | 11 | 0.140 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 252 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 279 | 0.140 |
Why?
|
BRCA1 Protein | 2 | 2016 | 1155 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.130 |
Why?
|
Flavonols | 1 | 2016 | 85 | 0.130 |
Why?
|
Raynaud Disease | 1 | 2017 | 79 | 0.130 |
Why?
|
Uric Acid | 1 | 2022 | 806 | 0.130 |
Why?
|
Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
Cholesterol, LDL | 6 | 2016 | 2398 | 0.130 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2016 | 39 | 0.130 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14784 | 0.130 |
Why?
|
Catechin | 1 | 2015 | 70 | 0.120 |
Why?
|
Nonsteroidal Anti-Androgens | 1 | 2015 | 9 | 0.120 |
Why?
|
Hyperlipidemias | 3 | 2012 | 773 | 0.120 |
Why?
|
Methionine | 1 | 2018 | 573 | 0.120 |
Why?
|
Macular Degeneration | 2 | 2013 | 1016 | 0.120 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 258 | 0.120 |
Why?
|
Quercetin | 1 | 2015 | 96 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 684 | 0.120 |
Why?
|
Candy | 1 | 2014 | 36 | 0.120 |
Why?
|
Young Adult | 22 | 2021 | 60049 | 0.120 |
Why?
|
Sex Characteristics | 3 | 2022 | 2660 | 0.120 |
Why?
|
Motor Vehicles | 1 | 1997 | 282 | 0.120 |
Why?
|
Estradiol | 2 | 2020 | 1952 | 0.120 |
Why?
|
Receptor, Insulin | 1 | 2018 | 838 | 0.120 |
Why?
|
Vitamin B Complex | 1 | 2017 | 299 | 0.120 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2016 | 453 | 0.120 |
Why?
|
Accidental Falls | 1 | 2023 | 1080 | 0.120 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2016 | 318 | 0.120 |
Why?
|
Leisure Activities | 1 | 2016 | 310 | 0.120 |
Why?
|
Trans-Activators | 2 | 2015 | 2856 | 0.120 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2016 | 640 | 0.110 |
Why?
|
Gastroenteritis | 1 | 2016 | 236 | 0.110 |
Why?
|
Fibrinolysis | 1 | 2015 | 331 | 0.110 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2014 | 88 | 0.110 |
Why?
|
Leukocytes | 2 | 2019 | 2030 | 0.110 |
Why?
|
Heart Failure | 5 | 2020 | 11858 | 0.110 |
Why?
|
Lipoproteins, HDL | 3 | 2019 | 682 | 0.110 |
Why?
|
Trans Fatty Acids | 1 | 2015 | 155 | 0.110 |
Why?
|
Alcohol Dehydrogenase | 1 | 2014 | 113 | 0.110 |
Why?
|
Reproductive History | 1 | 2015 | 210 | 0.110 |
Why?
|
China | 4 | 2021 | 2395 | 0.110 |
Why?
|
Streptococcal Infections | 1 | 2018 | 619 | 0.110 |
Why?
|
Tryptophan | 3 | 2023 | 482 | 0.110 |
Why?
|
Antibody Formation | 1 | 2018 | 1393 | 0.110 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2015 | 425 | 0.110 |
Why?
|
Insulin Resistance | 3 | 2014 | 3981 | 0.110 |
Why?
|
Prostatectomy | 4 | 2014 | 1841 | 0.110 |
Why?
|
Selenoprotein P | 1 | 2012 | 33 | 0.100 |
Why?
|
Iron | 1 | 2021 | 1814 | 0.100 |
Why?
|
Cardiovascular Agents | 1 | 2019 | 849 | 0.100 |
Why?
|
Survival Analysis | 9 | 2020 | 10117 | 0.100 |
Why?
|
Hypogonadism | 1 | 2019 | 805 | 0.100 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 69 | 0.100 |
Why?
|
Disease | 1 | 2017 | 673 | 0.100 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11254 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 375 | 0.100 |
Why?
|
Folic Acid | 2 | 2018 | 1336 | 0.100 |
Why?
|
Waist-Hip Ratio | 3 | 2019 | 520 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 268 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10776 | 0.100 |
Why?
|
Models, Cardiovascular | 2 | 2011 | 984 | 0.100 |
Why?
|
Depression | 2 | 2024 | 8241 | 0.100 |
Why?
|
Adolescent | 20 | 2023 | 89184 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2742 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2126 | 0.100 |
Why?
|
Lipogenesis | 1 | 2013 | 216 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2024 | 2062 | 0.100 |
Why?
|
Neopterin | 2 | 2023 | 57 | 0.100 |
Why?
|
Body Height | 3 | 2015 | 1568 | 0.090 |
Why?
|
Universities | 5 | 2018 | 1005 | 0.090 |
Why?
|
Boston | 5 | 2011 | 9371 | 0.090 |
Why?
|
Placebos | 3 | 2019 | 1668 | 0.090 |
Why?
|
Death Certificates | 3 | 2011 | 175 | 0.090 |
Why?
|
Pilot Projects | 2 | 2024 | 8731 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1780 | 0.090 |
Why?
|
Epidemiologic Methods | 3 | 2019 | 1337 | 0.090 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1943 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1190 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2016 | 11120 | 0.090 |
Why?
|
Counseling | 2 | 2014 | 1553 | 0.090 |
Why?
|
Patient Selection | 1 | 2002 | 4266 | 0.090 |
Why?
|
Eye Diseases | 1 | 2016 | 657 | 0.090 |
Why?
|
Nutrition Surveys | 2 | 2008 | 1736 | 0.090 |
Why?
|
Diet, Fat-Restricted | 2 | 2012 | 329 | 0.090 |
Why?
|
Weight Loss | 2 | 2020 | 2713 | 0.090 |
Why?
|
Neurotoxicity Syndromes | 1 | 2014 | 302 | 0.080 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1141 | 0.080 |
Why?
|
Milk | 1 | 2012 | 443 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2006 | 3431 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1119 | 0.080 |
Why?
|
Phenotype | 3 | 2018 | 16721 | 0.080 |
Why?
|
Kallikreins | 1 | 2011 | 219 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2013 | 538 | 0.080 |
Why?
|
Metabolomics | 1 | 2019 | 1674 | 0.080 |
Why?
|
Selenium | 1 | 2012 | 418 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2021 | 5313 | 0.080 |
Why?
|
Beer | 2 | 2008 | 135 | 0.080 |
Why?
|
Tissue Array Analysis | 3 | 2016 | 551 | 0.080 |
Why?
|
Gene Fusion | 1 | 2012 | 356 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4677 | 0.080 |
Why?
|
Wine | 2 | 2008 | 172 | 0.080 |
Why?
|
Heptanoic Acids | 1 | 2011 | 344 | 0.080 |
Why?
|
Population Density | 1 | 2009 | 193 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2948 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9510 | 0.080 |
Why?
|
Comorbidity | 8 | 2018 | 10588 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7064 | 0.080 |
Why?
|
Australia | 3 | 2018 | 1265 | 0.080 |
Why?
|
Alleles | 5 | 2019 | 6892 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2010 | 230 | 0.080 |
Why?
|
Models, Statistical | 2 | 2020 | 5099 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2021 | 405 | 0.080 |
Why?
|
Survival Rate | 8 | 2018 | 12870 | 0.080 |
Why?
|
Dyslipidemias | 2 | 2005 | 873 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2012 | 467 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2015 | 1410 | 0.070 |
Why?
|
Internet | 1 | 2000 | 3107 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2020 | 5151 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 587 | 0.070 |
Why?
|
Linkage Disequilibrium | 3 | 2021 | 1998 | 0.070 |
Why?
|
Antihypertensive Agents | 2 | 2015 | 2027 | 0.070 |
Why?
|
Alcoholic Beverages | 2 | 1999 | 266 | 0.070 |
Why?
|
Prevalence | 6 | 2023 | 15872 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2013 | 937 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3236 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2014 | 8051 | 0.070 |
Why?
|
Malus | 2 | 2005 | 51 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 930 | 0.070 |
Why?
|
Apolipoprotein A-I | 2 | 2019 | 305 | 0.070 |
Why?
|
Lipoproteins | 1 | 2011 | 880 | 0.070 |
Why?
|
Bleomycin | 2 | 2018 | 493 | 0.070 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2014 | 1039 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2010 | 755 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10844 | 0.070 |
Why?
|
Animals | 8 | 2019 | 169337 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 899 | 0.060 |
Why?
|
Etoposide | 2 | 2018 | 639 | 0.060 |
Why?
|
Death | 1 | 2010 | 683 | 0.060 |
Why?
|
Asia | 2 | 2018 | 627 | 0.060 |
Why?
|
Bicycling | 1 | 2007 | 177 | 0.060 |
Why?
|
Public Health | 2 | 2014 | 2682 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2442 | 0.060 |
Why?
|
Smoking Cessation | 2 | 2021 | 2083 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2812 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2296 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2011 | 1020 | 0.060 |
Why?
|
Oxidative Stress | 2 | 2014 | 3139 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1126 | 0.060 |
Why?
|
DNA Methylation | 2 | 2016 | 4421 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6210 | 0.060 |
Why?
|
Databases, Factual | 1 | 2000 | 8075 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2013 | 1389 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2341 | 0.060 |
Why?
|
Health Personnel | 2 | 2015 | 3380 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13503 | 0.060 |
Why?
|
Age Distribution | 5 | 2011 | 2877 | 0.060 |
Why?
|
Self Disclosure | 1 | 2005 | 249 | 0.060 |
Why?
|
Tocopherols | 1 | 2003 | 44 | 0.060 |
Why?
|
Brassica | 1 | 2003 | 39 | 0.050 |
Why?
|
Audiometry | 1 | 2024 | 253 | 0.050 |
Why?
|
Health Services Research | 1 | 2010 | 1817 | 0.050 |
Why?
|
Treatment Outcome | 9 | 2022 | 65379 | 0.050 |
Why?
|
Magnesium | 1 | 2006 | 816 | 0.050 |
Why?
|
Attitude to Health | 1 | 2012 | 2025 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 923 | 0.050 |
Why?
|
Parkinson Disease | 2 | 2007 | 2895 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2281 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2360 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2020 | 1748 | 0.050 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2005 | 371 | 0.050 |
Why?
|
Carbonated Beverages | 1 | 2023 | 210 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3826 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2021 | 7880 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3610 | 0.050 |
Why?
|
Acetaminophen | 2 | 2022 | 556 | 0.050 |
Why?
|
Genome, Human | 1 | 2015 | 4450 | 0.050 |
Why?
|
Brain Ischemia | 2 | 2006 | 3008 | 0.050 |
Why?
|
Coronary Artery Disease | 2 | 2019 | 6567 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2013 | 9198 | 0.050 |
Why?
|
Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
Adipokines | 1 | 2023 | 309 | 0.050 |
Why?
|
Sports | 3 | 2006 | 703 | 0.050 |
Why?
|
Meta-Analysis as Topic | 2 | 2016 | 1364 | 0.050 |
Why?
|
Triglycerides | 4 | 2016 | 2465 | 0.050 |
Why?
|
Europe | 3 | 2018 | 3439 | 0.050 |
Why?
|
Menopause | 2 | 2020 | 1653 | 0.050 |
Why?
|
Dietary Sucrose | 1 | 2003 | 243 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2593 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 246 | 0.050 |
Why?
|
Sweetening Agents | 1 | 2023 | 290 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4936 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2923 | 0.040 |
Why?
|
Retrospective Studies | 10 | 2023 | 81801 | 0.040 |
Why?
|
Health Services | 1 | 2006 | 756 | 0.040 |
Why?
|
United States Social Security Administration | 1 | 2000 | 10 | 0.040 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.040 |
Why?
|
Molecular Epidemiology | 2 | 2014 | 473 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2010 | 1802 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5168 | 0.040 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1885 | 0.040 |
Why?
|
Computational Biology | 3 | 2019 | 3543 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2016 | 6541 | 0.040 |
Why?
|
Predictive Value of Tests | 6 | 2016 | 15455 | 0.040 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2019 | 50 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2013 | 3985 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3623 | 0.040 |
Why?
|
Medical Records | 1 | 2005 | 1412 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5422 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14737 | 0.040 |
Why?
|
Estrogen Receptor beta | 1 | 2020 | 171 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2019 | 121 | 0.040 |
Why?
|
Genetic Markers | 2 | 2019 | 2604 | 0.040 |
Why?
|
Ampulla of Vater | 1 | 2019 | 150 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2103 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 403 | 0.040 |
Why?
|
Bile Ducts | 1 | 2020 | 288 | 0.040 |
Why?
|
MMPI | 1 | 1998 | 81 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6318 | 0.040 |
Why?
|
NAD | 1 | 2023 | 618 | 0.040 |
Why?
|
Insulin | 3 | 2019 | 6607 | 0.040 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 179 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7861 | 0.040 |
Why?
|
Frail Elderly | 1 | 2024 | 775 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Dietary Carbohydrates | 1 | 2003 | 896 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1727 | 0.040 |
Why?
|
Visual Acuity | 3 | 2013 | 2714 | 0.040 |
Why?
|
Beverages | 1 | 2023 | 819 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2018 | 93 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2018 | 127 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1150 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 12805 | 0.040 |
Why?
|
Pancreatitis, Chronic | 1 | 2020 | 282 | 0.040 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 624 | 0.030 |
Why?
|
Speech Reception Threshold Test | 1 | 2016 | 16 | 0.030 |
Why?
|
Family Health | 1 | 2001 | 1255 | 0.030 |
Why?
|
Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 2018 | 384 | 0.030 |
Why?
|
Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
Signal Transduction | 2 | 2018 | 23631 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5192 | 0.030 |
Why?
|
Massachusetts | 4 | 2011 | 8902 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3252 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 581 | 0.030 |
Why?
|
Adenoma | 1 | 2006 | 2163 | 0.030 |
Why?
|
Educational Status | 1 | 2003 | 2518 | 0.030 |
Why?
|
Audiometry, Pure-Tone | 1 | 2016 | 210 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 157 | 0.030 |
Why?
|
Cooperative Behavior | 2 | 2013 | 1515 | 0.030 |
Why?
|
Phlebotomy | 1 | 2016 | 138 | 0.030 |
Why?
|
Meat Products | 1 | 2015 | 97 | 0.030 |
Why?
|
European Union | 1 | 2016 | 157 | 0.030 |
Why?
|
Hearing Loss, Conductive | 1 | 2016 | 159 | 0.030 |
Why?
|
Kidney Calculi | 1 | 2019 | 469 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 1004 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7598 | 0.030 |
Why?
|
Drug Combinations | 2 | 2012 | 2079 | 0.030 |
Why?
|
Phospholipids | 1 | 1999 | 783 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2653 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1405 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 864 | 0.030 |
Why?
|
Liver Diseases | 1 | 2023 | 1304 | 0.030 |
Why?
|
Virulence | 1 | 2018 | 1298 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2016 | 369 | 0.030 |
Why?
|
Disabled Persons | 1 | 2024 | 1215 | 0.030 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2016 | 144 | 0.030 |
Why?
|
Albuminuria | 1 | 2018 | 658 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 784 | 0.030 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3164 | 0.030 |
Why?
|
Blood Glucose | 3 | 2019 | 6430 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2015 | 204 | 0.030 |
Why?
|
Drinking | 1 | 2015 | 197 | 0.030 |
Why?
|
Epididymitis | 1 | 2014 | 37 | 0.030 |
Why?
|
Food | 1 | 2019 | 768 | 0.030 |
Why?
|
Orchitis | 1 | 2014 | 36 | 0.030 |
Why?
|
Klinefelter Syndrome | 1 | 2014 | 48 | 0.030 |
Why?
|
Habits | 1 | 2014 | 147 | 0.030 |
Why?
|
Catalase | 1 | 2014 | 215 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 369 | 0.030 |
Why?
|
Morbidity | 1 | 1999 | 1758 | 0.030 |
Why?
|
Gynecomastia | 1 | 2014 | 88 | 0.030 |
Why?
|
Laboratories | 1 | 2017 | 463 | 0.030 |
Why?
|
Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 943 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 381 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 259 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1959 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15939 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 76 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4921 | 0.030 |
Why?
|
Risk Adjustment | 1 | 2016 | 603 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2015 | 410 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1126 | 0.020 |
Why?
|
Celiac Disease | 1 | 2020 | 820 | 0.020 |
Why?
|
Area Under Curve | 1 | 2016 | 1642 | 0.020 |
Why?
|
Veterans | 1 | 2006 | 2671 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1999 | 1322 | 0.020 |
Why?
|
Physical Examination | 1 | 2018 | 1262 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1608 | 0.020 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2013 | 300 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 595 | 0.020 |
Why?
|
Canada | 1 | 2017 | 2139 | 0.020 |
Why?
|
Bone Neoplasms | 2 | 2015 | 2565 | 0.020 |
Why?
|
Cholesterol, VLDL | 1 | 2011 | 70 | 0.020 |
Why?
|
Sweden | 1 | 2014 | 1383 | 0.020 |
Why?
|
Data Collection | 1 | 2000 | 3324 | 0.020 |
Why?
|
Serotonin | 1 | 2015 | 1045 | 0.020 |
Why?
|
Body Composition | 1 | 2000 | 2461 | 0.020 |
Why?
|
Caffeine | 1 | 2015 | 702 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1658 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2016 | 793 | 0.020 |
Why?
|
Testis | 1 | 2014 | 783 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7453 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9433 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2018 | 1468 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 911 | 0.020 |
Why?
|
United Arab Emirates | 1 | 2009 | 42 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2012 | 948 | 0.020 |
Why?
|
HIV Infections | 1 | 2016 | 17575 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 368 | 0.020 |
Why?
|
Reproduction | 1 | 2014 | 646 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2011 | 478 | 0.020 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2008 | 45 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 794 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 11918 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1539 | 0.020 |
Why?
|
Glioblastoma | 2 | 2015 | 3526 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1438 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5103 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1998 | 6034 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 1929 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2010 | 628 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2189 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3108 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2890 | 0.020 |
Why?
|
Androgens | 1 | 2015 | 1285 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2293 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1642 | 0.020 |
Why?
|
Thinness | 1 | 2010 | 483 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2012 | 1139 | 0.020 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 853 | 0.020 |
Why?
|
Particle Size | 1 | 2011 | 1653 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2986 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4291 | 0.020 |
Why?
|
Phytotherapy | 1 | 2008 | 298 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1766 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 14154 | 0.020 |
Why?
|
Cataract Extraction | 1 | 2010 | 465 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7145 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2015 | 2168 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2494 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2458 | 0.020 |
Why?
|
Recreation | 1 | 2006 | 124 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1428 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2635 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3813 | 0.020 |
Why?
|
Proline | 1 | 2006 | 455 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2012 | 20224 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1643 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3707 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8562 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10089 | 0.010 |
Why?
|
gamma-Tocopherol | 1 | 2003 | 29 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8753 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6006 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10478 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2257 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9516 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2008 | 2225 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 971 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3794 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2008 | 972 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2008 | 1724 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3827 | 0.010 |
Why?
|
Mass Screening | 1 | 2016 | 5451 | 0.010 |
Why?
|
Tennis | 1 | 2000 | 21 | 0.010 |
Why?
|
Physical Exertion | 1 | 2003 | 669 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20765 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14481 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2008 | 2194 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8506 | 0.010 |
Why?
|
Patient Compliance | 1 | 2008 | 2693 | 0.010 |
Why?
|
Mutation | 2 | 2015 | 30228 | 0.010 |
Why?
|
Child | 2 | 2019 | 80891 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5916 | 0.010 |
Why?
|
Epidemiologic Studies | 1 | 2001 | 678 | 0.010 |
Why?
|
Biomedical Research | 1 | 2013 | 3464 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2433 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6241 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 1209 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 22355 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2482 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18362 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11668 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1999 | 3438 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26411 | 0.010 |
Why?
|
Interviews as Topic | 1 | 1999 | 2740 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36510 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42650 | 0.010 |
Why?
|
Mice | 1 | 2014 | 82017 | 0.000 |
Why?
|
Patient Discharge | 1 | 1999 | 3476 | 0.000 |
Why?
|